5 participants
Study of Safety, Tolerability, and Efficacy of Ustekinumab for Symptomatic Gastrointestinal Inflammation Associated With Common Variable Immunodeficiency
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-08-24
- Start Date:
- 2015-10-19
- Completion:
- 2019-08-16
Conditions
- Gastrointestinal Inflammation Associated With CVID
- CVID Enteropathy
Interventions
- BIOLOGICAL